Daniell Richard sold TEVA

December 9, 2025 · Form 4 insider transaction

Daniell Richard sold 115,468 shares of Teva Pharmaceutical Industries Limited at $28.68 per share, a transaction worth $3.31M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
115,468
Price
$28.68
Total value
$3.31M
RoleOfficer
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateDecember 9, 2025
Filing dateDecember 11, 2025
Shares owned after48,384
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.635 to $28.765, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

View the original Form 4 on SEC EDGAR
Daniell Richard sold TEVA: December 9, 2025 | Insider Trading Screener